Scarica l'app Stockscreener
205.18
1.22%
2.47
Dopo l'orario di chiusura:
205.26
0.08
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$202.71
Aprire:
$201.29
Volume 24 ore:
1.43M
Relative Volume:
0.68
Capitalizzazione di mercato:
$58.46B
Reddito:
$21.84B
Utile/perdita netta:
$1.68B
Rapporto P/E:
35.20
EPS:
5.8293
Flusso di cassa netto:
$2.67B
1 W Prestazione:
+5.72%
1M Prestazione:
+8.27%
6M Prestazione:
+17.49%
1 anno Prestazione:
-12.48%
Intervallo 1D:
$201.29
$206.99
Intervallo di 1 settimana:
$192.48
$206.99
Portata 52W:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Confronta BDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
205.18 | 57.75B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
585.08 | 209.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
80.62 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.92 | 36.23B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.25 | 31.82B | 27.43B | 1.27B | 1.01B | 1.5829 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Is Becton Dickinson and Company (BOX) stock a top hedge fund pickJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
What to Expect From Becton, Dickinson and Company's Next Quarterly Earnings Report - inkl
Stifel raises Becton Dickinson stock price target to $215 from $210 - Investing.com UK
Stifel raises Becton Dickinson stock price target to $215 from $210 By Investing.com - Investing.com South Africa
The Truth About Becton Dickinson and Co (BDX): Quiet Healthcare Giant, Loud Money Moves - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces Blackout Period fo - GuruFocus
Becton Dickinson announces temporary blackout period for 401(k) plan stock fund - Investing.com
Becton Dickinson & CoOn Dec 30, Bd 401(K) Plan to Enter Blackout Period Due to Waters DealSEC Filing - TradingView — Track All Markets
Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst - Benzinga
Mcdaniel Terry & Co. Sells 74,357 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Bought by D.A. Davidson & CO. - MarketBeat
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $207 - 富途牛牛
BD Marks Milestone with First Phasix Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial - Finviz
RBC Sees Durable Growth Profile at Becton Dickinson (BDX), Raises Target - Insider Monkey
Becton, Dickinson and Company $BDX Shares Sold by Lazard Freres Gestion S.A.S. - MarketBeat
An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 40% Undervalued - Yahoo Finance UK
The Truth About Becton Dickinson & Co (BDX): Quiet Giant Or Sleeper Stock You’re Sleeping On? - AD HOC NEWS
Becton Dickinson announces temporary blackout period for 401(k) plan stock fund By Investing.com - Investing.com Nigeria
Becton, Dickinson and Company (NYSE:BDX) Shapes Global Healthcare - Kalkine Media
Becton Dickinson EVP sells $120,000 in company stock - MSN
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld, Becton Dickinson EVP, sells $14509 in stock By Investing.com - Investing.com Nigeria
Feld, Becton Dickinson EVP, sells $14509 in stock - Investing.com
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment - Quantisnow
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Quantisnow
Banque de Luxembourg S.A. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Franklin Lakes OKs affordable housing on Becton Dickinson site - Bergen Record
DAVENPORT & Co LLC Has $120.08 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX): Evaluating Valuation After New Immunology Partnership with University of Pennsylvania - Yahoo Finance
BD faces hernia mesh lawsuit from Tela Bio - MassDevice
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Trust Co. of Vermont Lowers Stake in Becton, Dickinson and Company $BDX - MarketBeat
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
BD and Penn Institute Ink Collaboration to Advance Immunotherapy - Yahoo Finance
IV Dressing Market Set for Dynamic Rise with Key Players Becton, - openPR.com
Is Becton Dickinson and Company stock a safe haven asset2025 Momentum Check & Accurate Trade Setup Notifications - ulpravda.ru
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
BECTON DICKINSON & CO ($BDX) CEO 2025 Pay Revealed - Quiver Quantitative
Form DEF 14A BECTON DICKINSON & CO For: Dec 12 - StreetInsider
Becton Dickinson, University of Pennsylvania partner on human immune profiling - TipRanks
Becton, Dickinson, University of Pennsylvania to Collaborate on Immune Profiling - 富途牛牛
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry - Finviz
Inside the 1,000-person immune study aiming to decode disease defenses - Stock Titan
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
BECTON DICKINSON Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
VP Garrison Sells 629 ($123.3K) Of Becton Dickinson & Co [BDX] - TradingView — Track All Markets
Can Becton Dickinson and Company (BOX) stock reach $200 price targetBear Alert & Verified Momentum Stock Alerts - Bollywood Helpline
The Magnificent 7 Are So Yesterday. These Are AI’s Next Big Winners - Forbes
RBC Capital Raises Becton Dickinson (BDX) Price Target to $210 | - GuruFocus
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $210 - 富途牛牛
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):